Literature DB >> 26900352

Tissue composition effect on dose distribution in neutron brachytherapy/neutron capture therapy.

Mohsen Khosroabadi1, Bagher Farhood2, Mahdi Ghorbani3, Nima Hamzian3, Homa Rezaei Moghaddam1, David Davenport4.   

Abstract

AIM: The aim of this study is to assess the effect of the compositions of various soft tissues and tissue-equivalent materials on dose distribution in neutron brachytherapy/neutron capture therapy.
BACKGROUND: Neutron brachytherapy and neutron capture therapy are two common radiotherapy modalities.
MATERIALS AND METHODS: Dose distributions were calculated around a low dose rate (252)Cf source located in a spherical phantom with radius of 20.0 cm using the MCNPX code for seven soft tissues and three tissue-equivalent materials. Relative total dose rate, relative neutron dose rate, total dose rate, and neutron dose rate were calculated for each material. These values were determined at various radial distances ranging from 0.3 to 15.0 cm from the source.
RESULTS: Among the soft tissues and tissue-equivalent materials studied, adipose tissue and plexiglass demonstrated the greatest differences for total dose rate compared to 9-component soft tissue. The difference in dose rate with respect to 9-component soft tissue varied with compositions of the materials and the radial distance from the source. Furthermore, the total dose rate in water was different from that in 9-component soft tissue.
CONCLUSION: Taking the same composition for various soft tissues and tissue-equivalent media can lead to error in treatment planning in neutron brachytherapy/neutron capture therapy. Since the International Commission on Radiation Units and Measurements (ICRU) recommends that the total dosimetric uncertainty in dose delivery in radiotherapy should be within ±5%, the compositions of various soft tissues and tissue-equivalent materials should be considered in dose calculation and treatment planning in neutron brachytherapy/neutron capture therapy.

Entities:  

Keywords:  252Cf; Dose rate; Neutron brachytherapy; Neutron capture therapy; Tissue composition

Year:  2015        PMID: 26900352      PMCID: PMC4716403          DOI: 10.1016/j.rpor.2015.05.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  12 in total

1.  Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.

Authors:  M J Rivard
Journal:  Med Phys       Date:  1999-08       Impact factor: 4.071

2.  Neutron dosimetry for a general 252Cf brachytherapy source.

Authors:  M J Rivard
Journal:  Med Phys       Date:  2000-12       Impact factor: 4.071

3.  Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.

Authors:  Mark J Rivard; Robert G Zamenhof
Journal:  Appl Radiat Isot       Date:  2004-11       Impact factor: 1.513

4.  Spatial and spectral characteristics of a compact system neutron beam designed for BNCT facility.

Authors:  J Ghassoun; B Chkillou; A Jehouani
Journal:  Appl Radiat Isot       Date:  2008-12-24       Impact factor: 1.513

5.  Detailed dose distribution prediction of Cf-252 brachytherapy source with boron loading dose enhancement.

Authors:  J Ghassoun; D Mostacci; V Molinari; A Jehouani
Journal:  Appl Radiat Isot       Date:  2009-10-14       Impact factor: 1.513

Review 6.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

7.  Boron neutron capture enhancement of 252Cf brachytherapy.

Authors:  J L Beach; C B Schroy; M Ashtari; M R Harris; Y Maruyama
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-06       Impact factor: 7.038

8.  Therapeutic potential of atmospheric neutrons.

Authors:  Cyril Voyant; Rudy Roustit; Jennifer Tatje; Katia Biffi; Delphine Leschi; Jérome Briançon; Céline Lantieri Marcovici
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-04

9.  Effect of tissue composition on dose distribution in brachytherapy with various photon emitting sources.

Authors:  Mahdi Ghorbani; Fateme Salahshour; Abbas Haghparast; Toktam Ahmadi Moghaddas; Courtney Knaup
Journal:  J Contemp Brachytherapy       Date:  2014-04-03

10.  The safety and usefulness of neutron brachytherapy and external beam radiation in the treatment of patients with gastroesophageal junction adenocarcinoma with or without chemotherapy.

Authors:  Qifeng Wang; Tao Li; Huiming Liu; Xitang Jia; Bo Liu; Xin Wan; Jinyi Lang
Journal:  Radiat Oncol       Date:  2014-04-29       Impact factor: 3.481

View more
  6 in total

1.  Evaluating the performance of TG-43 protocol in esophageal HDR brachytherapy viewpoint to trachea inhomogeneity.

Authors:  Seyed Mohsen Hosseini Daghigh; Hamid Reza Baghani; Seyed Mahmoud Reza Aghamiri; Seyed Rabi Mahdavi
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

2.  Effects of Siemens TT-D carbon fiber table top on beam attenuation, and build up region of 6 MV photon beam.

Authors:  Asma Sheykhoo; Sara Abdollahi; Mohammad Hadi Hadizadeh Yazdi; Mahdi Ghorbani; Mohammad Mohammadi
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-17

Review 3.  Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.

Authors:  Bagher Farhood; Hadi Samadian; Mahdi Ghorbani; Seyed Salman Zakariaee; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-01

4.  Presenting and simulating an innovative model of liver phantom and applying two methods for dosimetry of it in neutron radiation therapy.

Authors:  Seyed Alireza Mousavi Shirazi; Ali Pazirandeh; Gholamreza Jahanfarnia; Mitra Athari Allaf
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-27

5.  Assessment of dose uniformity around high dose rate 192Ir and 60Co stepping sources.

Authors:  Bagher Farhood; Mahdi Ghorbani
Journal:  Radiol Phys Technol       Date:  2017-09-18

6.  Detailed analysis of dose difference in using water as tissue-equivalent material in 252Cf brachytherapy.

Authors:  Izadi Vasafi Gholamhossein; Mehdi Firoozabadi Mohammad; Ghorbani Mahdi
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.